Table of Contents Table of Contents
Previous Page  10 / 11 Next Page
Information
Show Menu
Previous Page 10 / 11 Next Page
Page Background

World Biochem 2019 & Regenerative Medicine 2019

Journal of Genetics and Molecular Biology | Volume 3

Page 38

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

March 25-26, 2019 | Amsterdam, Netherlands

&

BIOCHEMISTRY AND ENZYMOLOGY

World Congress on

TISSUE ENGINEERING AND REGENERATIVE MEDICINE, STEM CELL RESEARCH

2

nd

Global Conference on

Joint Event on

INVESTIGATING THE CELLULAR

DYNAMICS OF ORGANS

DEVELOPMENT AND CANCER USING

3D IMAGING

R

ios implemented a novel 3D-imaging approach (with 3D glasses) to

perform innovative multicoloured lineage tracing studies to follow the

development and fate of mammary stem cells (MaSC) and descendant

progenitor cells

in vivo

in entire mammary gland. As stem cells divide they

produce clones of cells; using this imaging technique the fate of these in-

dividual clones could be tracked throughout various stages of mammary

gland development, including puberty, pregnancy and normal adult ho-

meostasis. This work provided the first

in vivo

evidence for the existence

of bipotent MaSCs, which give rise to the two cell lineages that constitute

the mammary ducts, the luminal and the myoepithelial cells, as well as

the presence of distinct long-lived unipotent progenitor cells. The cellular

dynamics observed at different developmental stages support a model in

which both stem and progenitor cells drive morphogenesis during puber-

ty, whereas bipotent MaSCs coordinate ductal homeostasis and remod-

elling of the adult mouse gland (Nature 2014, Nature Comm. 2016, NCB

2017). We have now specialized this 3D technology combined with the

multicolored reporter confetti to detect early aberrant cellular behaviour

in models of breast cancer and to visualise how cancerous cells, accord-

ing to their cell-of-origin, exit normal ductal homeostasis and survive to

self-organise into a solid tumour.

Anne Rios, J Genet Mol Biol 2019, Volume 3

Anne Rios obtained her PhD in 2011. Her

work represented a novel cell signalling

mechanism that triggers the differentiation

of a defined subset of cells within a stempool

(Nature, 2011). Then she joined in the labo-

ratory of professors Jane Visvader and Geoff

Lindeman focusing on breast cancer. In 2016,

she received the Medical Innovation Award

(Centenary Institute Lawrence Creative Prize

Winner) for her postdoctoral’s work (Nature,

2014). In 2017, she was appointed group

leader at the Princess Máxima Center and

head the Princess Máxima Imaging Centre.

She is currently investigating the cellular

mechanisms underlying pediactric and adult

solid tumor progression using State-of-the-

art imaging technologies.

a.c.rios@prinsesmaximacentrum.nl

Anne Rios

Princess Maxima Center of Pediatric Oncology, Netherlands

BIOGRAPHY